CoChat

A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline

Open access
McMullin, Mary Frances, Harrison, Claire N., Ali, Sahra, Cargo, Catherine, Chen, Frederick, Ewing, Joanne, Garg, Mamta, Godfrey, Anna, S, Steven Knapper, McLornan, Donal P., Nangalia, Jyoti, Sekhar, Mallika, Wadelin, Frances, Mead, Adam J., the BSH Committee · 2019 · British Journal of Haematology
Cited by 161

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Abstract

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bjh.15648

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

    Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119 · cited 3×

    “…JAK 2 V617F mutation, haemoglobin concentration and/or Hct are currently used as a surrogate for RCM to distinguish between PV and essential thrombo-cythaemia (ET) (Arber et al , 2016), but Hct has the better accuracy in predicting RCM (Alvarez-Larr (cid:1) an et al , 2012; Ancochea et al , 2014).”
    BackgroundMethod
  • Age-related clonal hematopoiesis associated with adverse outcomes

    Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · cited 2×

    “However, the JAK 2 V617F mutation has been identified in normal individuals, often at a low allele burden, with a frequency that increases with age (Gen-ovese et al , 2014; Jaiswal et al , 2014).”
    Background
  • Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

    Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531

  • JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis

    Scott, L. M., Tong, W., Levine, R. L., Scott, M. A., Beer, P. A., Stratton, M. R., Futreal, P. A., Erber, W. N., McMullin, M. F., Harrison, C. N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065202 · Cited by 1,276 · cited 2×

    “…patients with exon 12 mutated-PV tend to be younger, with higher haemoglobin concentrations, lower white blood cell (WBC) and platelet counts, and an isolated increase in erythropoiesis without granulocytic or megakaryocytic morphological abnormalities (Scott et al , 2007; Passamonti et al , 2011).”
    BackgroundSelf-citation
  • Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

    Landolfi, R., Marchioli, R., Kutti, J., Gisslinger, H., Tognoni, G., Patrono, C., & Barbui, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035572 · Cited by 1,012

  • Ruxolitinib versus standard therapy for the treatment of polycythemia vera

    Vannucchi, A. M., Kiladjian, J. J., Griesshammer, M., Masszi, T., Durrant, S., Passamonti, F., Harrison, C. N., Pane, F., Zachee, P., Mesa, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1409002 · Cited by 891 · cited 2×

    “Following this, a phase III trial RESPONSE evaluated the efficacy and safety of ruxolitinib in a specific subgroup of PV patients who were both refractory to, or intolerant of, HC and who required ongoing phlebotomy and had splenomegaly (Vannucchi, 2015).”
    MethodSelf-citation
  • Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

    Marchioli, R., Finazzi, G., Specchia, G., Cacciola, R., Cavazzina, R., Cilloni, D., De Stefano, V., Elli, E., Iurlo, A., Latagliata, R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208500 · Cited by 846 · cited 5×

    “This target has now been validated in a randomised clinical trial by the Cytoreductive Therapy in PV (CYTO-PV) investigators who assessed the impact of stringent Hct reduction to 0 (cid:1) 45 compared with a more liberal target range of 0 (cid:1) 45 – 0 (cid:1) 50 (Marchioli et al , 2013).”
    BackgroundMethodInfluential
  • Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis

    Cortelazzo, S., Finazzi, G., Ruggeri, M., Vestri, O., Galli, M., Rodeghiero, F., & Barbui, T. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504273321704 · Cited by 843 · cited 1×

    “The efficacy of HC in controlling blood counts and preventing thrombosis has been extrapolated from the evidence in ET (Cortelazzo et al , 1995) and HC has been used in the management of PV.”
    Method
  • Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

    Marchioli, R., Finazzi, G., Landolfi, R., Kutti, J., Gisslinger, H., Patrono, C., Marilus, R., Villegas, A., Tognoni, G., & Barbui, T. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.062 · Cited by 726 · cited 3×

    “At diagnosis, in the largest prospective study to date, the European Collaboration on Low-Dose Aspirin in Poly-cythaemia Vera (ECLAP), age ≥ 65 years and a prior history of thrombosis were found to be the most important predictors of cardiovascular events (Marchioli et al , 2005).”
    Background
  • Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

    Tefferi, A., Rumi, E., Finazzi, G., Gisslinger, H., Vannucchi, A. M., Rodeghiero, F., Randi, M. L., Vaidya, R., Cazzola, M., Rambaldi, A., et al. (2013) · Leukemia · doi:10.1038/leu.2013.163 · Cited by 700 · cited 9×

    “A long-term assessment from the ECLAP study showed no increased MDS/AML in those treated with HC alone (Finazzi et al , 2005) and a retrospective analysis showed no association between HC or busulfan and AML (Tefferi et al , 2013).”
    BackgroundMethodInfluential

Show all 70 references

Metadata

Authors
McMullin, M. F., Harrison, C. N., Ali, S., Cargo, C., Chen, F., Ewing, J., Garg, M., Godfrey, A., S, S. K., McLornan, D. P., Nangalia, J., Sekhar, M., Wadelin, F., Mead, A. J., & the BSH Committee
Venue
British Journal of Haematology
Publisher
Wiley
Published
2018-11-27
Volume
184
Issue
2
Pages
176-191
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W2903319422
Cited by
161
References
70
FWCI
7.36
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. https://app.cochat.ai/papers/10.1111/bjh.15648
The paper
McMullin, M. F., Harrison, C. N., Ali, S., Cargo, C., Chen, F., Ewing, J., Garg, M., Godfrey, A., S, S. K., McLornan, D. P., Nangalia, J., Sekhar, M., Wadelin, F., Mead, A. J., & the BSH Committee. (2019). A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. British Journal of Haematology. https://doi.org/10.1111/bjh.15648

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.